GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (TSXV:HEM) » Definitions » Other Liabilities for Insurance Companies

Hemostemix (TSXV:HEM) Other Liabilities for Insurance Companies


View and export this data going back to 2012. Start your Free Trial

What is Hemostemix Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Hemostemix (TSXV:HEM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (TSXV:HEM) » Definitions » Other Liabilities for Insurance Companies
Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Executives
Thomas Smeenk Director